Marie Flanagan

Marie Flanagan, Regulatory and AI governance lead at IQVIA Safety Technologies with ~20 years in pharmacovigilance, talks about aligning AI with regulatory frameworks. She covers shared responsibility across teams. She explains platform-level governance and seven guiding principles. She highlights continuous monitoring, human-in-loop design, bias detection, and baking guardrails into system design.

Marie Flanagan, Director of Product Management at IQVIA, delves into the transformative impact of AI and automation on drug safety workflows. She discusses how natural language processing (NLP) and automation tools enhance adverse event detection, especially through social media monitoring. Marie highlights the partnership between technology and regulatory bodies like the FDA, emphasizing a shift towards transparent, patient-centric safety practices. She also stresses the importance of optimizing workflows before digital adoption to maximize the benefits of AI in healthcare.

Marie Flanagan, a Director at IQVIA, dives into the exciting intersection of AI and safety workflows in healthcare. She discusses the surge in data complexity, from social media insights to audio recordings, posing challenges for pharmacovigilance. Marie highlights how AI tools like voice-to-text transcription are revolutionizing data management, allowing safety teams to focus on critical tasks. She stresses the irreplaceable role of human judgment in interpreting nuanced clinical situations, showcasing a balanced approach to enhance patient safety.